Comparison of the Efficacy and Safety of Dapoxetine, Kegel Exercises, and Acupuncture in the Treatment of Premature Ejaculation: A Randomized, Double-Blind, Placebo-Controlled Trial
NCT07067970 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250
Last updated 2025-07-16
Summary
This study aims to compare the efficacy and safety of dapoxetine, Kegel exercises, acupuncture, and their placebo controls in the treatment of premature ejaculation (PE). PE is a common male sexual dysfunction characterized by ejaculation occurring within one minute of vaginal penetration, causing distress or interpersonal difficulties (Althof et al., 2014). A total of 250 male participants will be randomized into five groups (dapoxetine, placebo, Kegel exercises, acupuncture, sham acupuncture) for a 12-week treatment period followed by a 4-week follow-up. The primary outcome is the increase in intravaginal ejaculation latency time (IELT), with secondary outcomes including the Premature Ejaculation Diagnostic Tool (PEDT) score, Sexual Quality of Life-Male (SQoL-M) score, and adverse effects.
Conditions
- Premature Ejaculation
Interventions
- DRUG
-
serotonin reuptake inhibitor (SSRI)
Dapoxetine Group Dosage: 30 mg dapoxetine, taken orally 1-3 hours before anticipated sexual activity, with a maximum of 3 doses per week. Administration: Provided in blister packs to ensure compliance. Reference: McMahon et al., 2011.
- DRUG
-
Dosage: Placebo tablets identical in appearance and taste to dapoxetine, administered on the same schedule (1-3 hours before sexual activity, maximum 3 doses per week). Administration: Provided in identical blister packs.
- OTHER
-
Acupuncture
Protocol: Two 30-minute acupuncture sessions per week, targeting standardized points (e.g., CV4, SP6, ST36) known to influence sexual function and autonomic nervous system regulation. Administration: Performed by licensed acupuncturists following a standardized protocol. Reference: Sunay et al., 2011.
- OTHER
-
Sham
Sham Acupuncture Group:Protocol: Two 30-minute sessions per week using superficial needle insertion at non-active points to minimize therapeutic effects while maintaining the placebo effect. Administration: Performed by licensed acupuncturists to ensure consistency with the active acupuncture group
- BEHAVIORAL
-
Exercise
Kegel Exercises Group:Protocol: Participants will perform pelvic floor muscle exercises consisting of three sets of 10-15 contractions daily, each held for 5-10 seconds followed by relaxation. Training: Participants will receive initial training from a licensed physiotherapist, with weekly follow-up sessions to ensure proper technique and adherence. Reference: Pastore et al., 2014.
Sponsors & Collaborators
-
Medipol University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-10-01
- Primary Completion
- 2026-10-01
- Completion
- 2026-12-01
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Therapeutic Outcomes of Selective Serotonin Reuptake Inhibitors and Phosphodiesterase-5 Inhibitors Combination Therapy Versus Monotherapy
NCT07057011 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation.
NCT00211107 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation
NCT00211094 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial to Evaluate the Efficacy and Safety of DA-8031 in Male Patients With Premature Ejaculation
NCT01798667 ·Status: UNKNOWN ·Phase: PHASE2
-
Proof of Concept Study on BP1.4979 Effect on Primary Premature Ejaculation
NCT07047404 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature Ejaculation
NCT00210613 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy and Safety of Dapoxetine/Sildenafil Combination Therapy
NCT02939495 ·Status: COMPLETED ·Phase: PHASE4
-
An Observational Study of Men With Premature Ejaculation Who Are Treated With Dapoxetine Hydrochloride or Alternate Care Defined as Any Treatment Other Than Dapoxetine Hydrochloride
NCT01021670 ·Status: COMPLETED
-
Investigation of the Changes of Brain Structure and Function in Premature Ejaculation Patients and the Effects of Dapoxetine on Central Neural Activity in Premature Ejaculation Patients
NCT03583112 ·Status: UNKNOWN ·Phase: NA
-
Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044
NCT01419470 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Exploratory Study of Pagoclone in Men With Premature Ejaculation.
NCT00370981 ·Status: COMPLETED ·Phase: PHASE2
-
Concomitant Use of PriLigy in Men Treated for Erectile Dysfunction
NCT01063855 ·Status: COMPLETED ·Phase: PHASE3
-
The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation Therapy
NCT01063881 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Efficacy and Safety of UK-390,957 in Men With Premature Ejaculation
NCT00143117 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Discontinuation of Dapoxetine Treatment in Patients With Premature Ejaculation
NCT03018743 ·Status: UNKNOWN
-
Efficacy and Safety of Paroxetine Daily Doses of 15 mg and 20 mg in the Treatment of Premature Ejaculation
NCT01024491 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Characterize the Pharmacokinetics of DA-8031 in Healthy Male Subjects
NCT01104948 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Intravaginal Ejaculation Time in Men With and Without Premature Ejaculation
NCT00210678 ·Status: COMPLETED
-
Pelvic Floor Muscle Training in the Treatment of Erectile Dysfunction
NCT05385822 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness and Tolerability of Lidocaine 5% Spray in Treatment of Lifelong Premature Ejaculation Patients.
NCT04062357 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Clinical Efficacy and Safety of Dapoxetine, Combined Dapoxetine With Folic Acid and Combined Dapoxetine With Vitamin B12 in Treatment of Patients With Premature Ejaculation
NCT04085354 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2 Study of On-demand Therapy With Clomipramine and Sildenafil Combination in Premature Ejaculation
NCT02571101 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation
NCT01021553 ·Status: COMPLETED ·Phase: PHASE2
-
PSD502 in Subjects With Premature Ejaculation
NCT03578783 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-Label Study of the Long-Term Safety of Dapoxetine HCl in the Treatment of Rapid Ejaculation
NCT01230762 ·Status: COMPLETED ·Phase: PHASE3